Lumosag, Linda .

HRN: 27-20-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/05/2025
06/12/2025
IV
4.5g
Q8
Fever Of Malignancy
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: